TY - JOUR
T1 - Molecular Mechanisms of Vascular Health
T2 - Insights From Vascular Aging and Calcification
AU - Sutton, Nadia R.
AU - Malhotra, Rajeev
AU - Hilaire, Cynthia St.
AU - Aikawa, Elena
AU - Blumenthal, Roger S.
AU - Gackenbach, Grace
AU - Goyal, Parag
AU - Johnson, Adam
AU - Nigwekar, Sagar U.
AU - Shanahan, Catherine M.
AU - Towler, Dwight A.
AU - Wolford, Brooke N.
AU - Chen, Yabing
N1 - Funding Information:
N.R. Sutton is an Advisor for Philips and Abbott and receives Honoraria from Zoll, Abbott, Shockwave, and Cordis. R. Malhotra—sponsored research agreement for Amgen, Bayer; Consultant for Renovocor, Third Pole, Myokardia (now Bristol Myers Squibb). S.N. Nigwekar is a Consultant for Epizon Pharma, Laboratoris Sanifit, Inozyme Pharma and reports grant support from Hope Pharma, Laboratoris Sanifit, Inozyme Pharma. P. Goyal is a Consultant for Sensorum Health. The other authors report no conflicts.
R. Malhotra was supported by the National Heart, Lung, and Blood Institute (R01HL142809), the American Heart Association (18TPA34230025), and the Wild Family Foundation. E. Aikawa is supported by research grants from the National Institutes of Health R01HL136431, R01HL141917, and R01HL147095. C.S. Hilaire holds grants from the National Institutes of Health (HL142932) and the American Heart Association (20IPA35260111). B.N. Wolford is funded by the European Union H2020 Research and Innovation programme INTERVENE (International Consortium for Integrative Genomics Prediction), grant no. 101016775. N.R. Sutton National Institute on Aging 1K76AG064426-01A1. P. Goyal is supported by American Heart Association grant 20CDA35310455, National Institute on Aging grant K76AG064428, and Loan Repayment Program award L30AG060521. S.U. Nigwekar is supported by the National Institute of Biomedical Imaging and Bioengineering (1R01EB031813-01A1) and by the National Institute of Diabetes and Digestive and Kidney Diseases (1U01DK123818-01). C.M. Shanahan is supported by grants from the British Heart Foundation (RG/17/2/32808). D.A. Towler is supported by grants from the National Institutes of Health (HL069229-21), American Diabetes Association (1-18-IBS-224), and the Pak Center for Mineral Metabolism Research. Y. Chen is supported by grants from the National Institutes of Health (HL136165, HL146103 and HL158097) as well as United States Department of Veterans Affairs Basic Sciences R&D Service (BX005800 and BX004426).
Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Cardiovascular disease is the most common cause of death worldwide, especially beyond the age of 65 years, with the vast majority of morbidity and mortality due to myocardial infarction and stroke. Vascular pathology stems from a combination of genetic risk, environmental factors, and the biologic changes associated with aging. The pathogenesis underlying the development of vascular aging, and vascular calcification with aging, in particular, is still not fully understood. Accumulating data suggests that genetic risk, likely compounded by epigenetic modifications, environmental factors, including diabetes and chronic kidney disease, and the plasticity of vascular smooth muscle cells to acquire an osteogenic phenotype are major determinants of age-associated vascular calcification. Understanding the molecular mechanisms underlying genetic and modifiable risk factors in regulating age-associated vascular pathology may inspire strategies to promote healthy vascular aging. This article summarizes current knowledge of concepts and mechanisms of age-associated vascular disease, with an emphasis on vascular calcification.
AB - Cardiovascular disease is the most common cause of death worldwide, especially beyond the age of 65 years, with the vast majority of morbidity and mortality due to myocardial infarction and stroke. Vascular pathology stems from a combination of genetic risk, environmental factors, and the biologic changes associated with aging. The pathogenesis underlying the development of vascular aging, and vascular calcification with aging, in particular, is still not fully understood. Accumulating data suggests that genetic risk, likely compounded by epigenetic modifications, environmental factors, including diabetes and chronic kidney disease, and the plasticity of vascular smooth muscle cells to acquire an osteogenic phenotype are major determinants of age-associated vascular calcification. Understanding the molecular mechanisms underlying genetic and modifiable risk factors in regulating age-associated vascular pathology may inspire strategies to promote healthy vascular aging. This article summarizes current knowledge of concepts and mechanisms of age-associated vascular disease, with an emphasis on vascular calcification.
KW - aging
KW - cardiovascular disease
KW - morbidity
KW - mortality
KW - risk factors
UR - http://www.scopus.com/inward/record.url?scp=85144592301&partnerID=8YFLogxK
U2 - 10.1161/ATVBAHA.122.317332
DO - 10.1161/ATVBAHA.122.317332
M3 - Review article
C2 - 36412195
AN - SCOPUS:85144592301
SN - 1079-5642
VL - 43
SP - 15
EP - 29
JO - Arteriosclerosis, Thrombosis, and Vascular Biology
JF - Arteriosclerosis, Thrombosis, and Vascular Biology
IS - 1
ER -